9 Results for "

vacuolar-H+-ATPase

" in MedChemExpress (MCE) Product Catalog:
Products (9)

9 Results for "vacuolar-H+-ATPase" in MCE Product Catalog:

909
909 Publications Verification
Cat. No.: HY-100558
CAS No.: 88899-55-2
Purity:  99.95%
Synonyms: BafA1
Bafilomycin A1 (BafA1) is a specific and reversible inhibitor of vacuolar H +-ATPase (V-ATPase) with IC50 values of 4-400 nmol/mg. Bafilomycin A1, a macrolide antibiotic, is also used as an autophagy inhibitor at the late stage. Bafilomycin A1 blocks autophagosome-lysosome fusion and inhibits acidification and protein degradation in lysosomes of cultured cells. Bafilomycin A1 induces apoptosis .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-A0213A
CAS No.: 149845-07-8
Synonyms: Tiludronic acid disodium
Target:  

Proton Pump

Research Areas:  

Inflammation/Immunology

Tiludronate (Tiludronic Acid) disodium, an orally active bisphosphonate, can act an osteoregulator. Tiludronate is used for the research of the metabolic bone disorders. Tiludronate is a potent inhibitor of the osteoclast vacuolar H(+)-ATPase. Antiresorptive and anti-inflammatory properties .
loading...
    loading...
Cat. No.: HY-176954
CAS No.: 2171015-78-2
Research Areas:  

Cancer

RSC-1255 is a potent and selective Vacuolar H⁺-ATPase (V-ATPase) inhibitor that directly binds the mammalian V-ATPase complex with a Kd = 23 nM. RSC-1255 exhibits preferential cytotoxicity toward KRAS-mutant cancer cells, especially KRAS G13D and KRAS G12V cells. RSC-1255 induces apoptosis and blocks lysosomal acidification, autophagy, and macropinocytosis in cancer cells. RSC-1255 can be used for the study of KRAS-driven lung and colon cancers .
loading...
    loading...
Cat. No.: HY-A0213
CAS No.: 89987-06-4
Synonyms: Tiludronic acid
Target:  

Proton Pump

Research Areas:  

Inflammation/Immunology

Tiludronate (Tiludronic Acid), an orally active bisphosphonate, can act an osteoregulator. Tiludronate is used for the research of the metabolic bone disorders. Tiludronate is a potent inhibitor of the osteoclast vacuolar H(+)-ATPase. Antiresorptive and anti-inflammatory properties .
loading...
    loading...
Cat. No.: HY-A0213AS
Synonyms: Tiludronic acid-d5 sodium
Tiludronate-d5 (sodium)mis the deuterium labeled Tiludronate disodium. Tiludronate (Tiludronic Acid) disodium, an orally active bisphosphonate, can act an osteoregulator. Tiludronate is used for the research of the metabolic bone disorders. Tiludronate is a potent inhibitor of the osteoclast vacuolar H(+)-ATPase. Antiresorptive and anti-inflammatory properties .
loading...
    loading...
Cat. No.: HY-A0213B
CAS No.: 155453-10-4
Synonyms: Tiludronic acid disodium hemihydrate
Target:  

Proton Pump

Research Areas:  

Metabolic Disease

Tiludronate (Tiludronic Acid) disodium hemihydrate, an orally active bisphosphonate, can act an osteoregulator. Tiludronate disodium hemihydrate is used for the research of the metabolic bone disorders. Tiludronate disodium hemihydrate is a potent inhibitor of the osteoclast vacuolar H +-ATPase. Antiresorptive and anti-inflammatory properties .
loading...
    loading...
Cat. No.: HY-187719
CAS No.: 318262-42-9
Target:  

Proton Pump Apoptosis

Research Areas:  

Cancer

NIK-12192 is an orally active inhibitor of vacuolar H +-ATPase. NIK-12192 reduces intracellular pH, decreases lysosomal volume and acidity, and alters the intracellular localization of V-ATPase by inhibiting proton pumps . NIK-12192 induces αvβ5 integrin polarization, cytoskeletal disruption, cell detachment, anoikis-mediated delayed apoptosis and necrosis, a delayed reduction in mitochondrial membrane potential, and lysosomal/phagosomal accumulation. NIK-12192 inhibits tumor cell migration, invasion, and three-dimensional spheroid growth, and enhances the activity of Topotecan (HY-13768). NIK-12192 suppresses spontaneous lung metastasis in vivo. NIK-12192 is used in research related to colon cancer, ovarian cancer, lung cancer, breast cancer, renal cancer, prostate cancer, acute myeloid leukemia, and melanoma .
loading...
    loading...
Cat. No.: HY-183975
Target:  

Fungal

Research Areas:  

Infection

V-ATPase-IN-2 is an inhibitor targeting the a-c subunits of vacuolar H +-ATPase (V-ATPase), with an EC50 of 8.449 μg/mL against Phytophthora capsici. V-ATPase-IN-2 causes significant vacuolar enlargement and ultrastructural damage in Phytophthora capsici cells, and also inhibits sporangium formation, zoospore release, and cyst germination of this pathogen. V-ATPase-IN-2 can be used in studies related to Phytophthora capsici infection .
loading...
    loading...
Cat. No.: HY-100558R
CAS No.: 88899-55-2
Synonyms: BafA1 (Standard)
Bafilomycin A1 (Standard) is the analytical standard of Bafilomycin A1 (HY-100558). This product is intended for research and analytical applications. Bafilomycin A1 (BafA1) is a specific and reversible inhibitor of vacuolar H +-ATPase (V-ATPase) with IC50 values of 4-400 nmol/mg. Bafilomycin A1, a macrolide antibiotic, is also used as an autophagy inhibitor at the late stage. Bafilomycin A1 blocks autophagosome-lysosome fusion and inhibits acidification and protein degradation in lysosomes of cultured cells. Bafilomycin A1 induces apoptosis .
loading...
    loading...